This site is intended for healthcare professionals only
LoginRegister
Panacea Biotec announces listing of EmulsiPan adjuvant in CEPI Adjuvant LibraryPanacea Biotec announces listing of EmulsiPan adjuvant in CEPI Adjuvant Library
SEC Approves Serums Salk Polio Vaccine for Commercial Use, Recommends Phase I Trial for 21-valent Pneumococcal VaccineSEC Approves Serum's Salk Polio Vaccine for Commercial Use, Recommends Phase I Trial for 21-valent...
Morepen Labs names Vivan Prashar as functional head, (Operations-API)Morepen Labs names Vivan Prashar as functional head, (Operations-API)
NPPA sets retail prices for 41 drugs, including 29 Fixed-Dose Combinations containing Empagliflozin or SitagliptinNPPA sets retail prices for 41 drugs, including 29 Fixed-Dose Combinations containing Empagliflozin...
Roche Susvimo maintains vision over five years with two refills per year in people with nAMDRoche Evrysdi tablet gets European Commission approval for Spinal Muscular Atrophy
Novartis concludes acquisition of Regulus TherapeuticsZydus Lifesciences to acquire India, Sri Lanka rights for Agenus cancer immunotherapy BOT/BAL
Takeda gets USFDA 510(k) clearance for HyHub, HyHub Duo devices to simplify HYQVIA administrationTakeda Adcertris combo approved by European Commission for newly diagnosed Stage IIb/III/IV Hodgkin...
Doctors asked to only prescribe medicines available in hospital pharmacyCDSCO Panel Seeks Revised Protocol for Green Signal's BCG Vaccine PMS Study
Dr Reddys Secures CDSCO Panel Approval to Import, Market Olutasidenib for AMLCancer drug: Dr Reddy's Labs, Alvotech ink pact to codevelop biosimilar candidate to Keytruda
Haleon elevates Sachin Bhatnagar to VP - Head of Procurement EMEAHaleon appoints Sachin Bhatnagar as VP - Head of Procurement EMEA
CDSCO Panel Recommends Phase III Trial of Tetanus Vaccine by Indian Immunologicals in Pregnant WomenCDSCO Panel Recommends Phase III Trial of Tetanus Vaccine by Indian Immunologicals in Pregnant Women
MSN Labs Gets SEC Nod to Conduct Phase III Trial of SemaglutideMSN Labs Gets SEC Nod to Conduct Phase III Trial of Semaglutide
X